Arkolith/Insider Trading/AXDX/Form 4

Patience David

Chief Financial OfficerAccelerate Diagnostics, Inc (AXDX) · full profile →Form 4 · filed Feb 27, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$336
Net Open-Market Flow
-$336
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 26, 2024Option exercise(M)1K—$027K
Feb 26, 2024Sell(S)350$0.96$33626K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 26, 2024Option exercise(M)1K—$02K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-028325) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML